Impact
Our Guiding Principles
Our Commitment
At PEAL Capital, we believe responsible investing means pursuing more than financial returns. By focusing on longevity and health optimisation, we back companies that deliver measurable improvements to people’s lives while maintaining rigorous governance and strong stakeholder alignment.
Across Fund I, our unified platform, combining accredited medical training with premium clinical services, enables us to scale efficiently in the UK and internationally, create compelling cross-selling opportunities, and position the business for an attractive future exit. This integrated strategy transforms responsible investment into long-term, resilient value.
Social Impact
Improving Lives Through Healthcare
We invest exclusively in businesses that deliver diagnostic, therapeutic, and educational solutions in longevity and hormone health. Supported by a unified digital platform active in 68 countries, these companies advance patient wellbeing, preventive care, and accredited professional training.
Newly certified clinicians transition directly into our clinics, creating an end-to-end pathway from education to patient treatment. This integrated model elevates clinical standards globally while unlocking significant cross-selling opportunities across the entire patient journey.
Unified medical training platform scaling access to longevity and hormone education
Clinics delivering diagnostics, telemedicine and in-person treatment
Businesses focused on outcomes-driven, evidence-based care
Responsible Investment, Global Impact
We integrate ESG principles throughout our investment lifecycle, focusing on good governance, inclusive leadership, and measurable environmental awareness. Our approach ensures every portfolio company contributes to long-term, sustainable value creation.
Governance & Accountability
We take influential or controlling positions and hold board seats to guide governance decisions directly. In many cases, we step in through interim roles or executive support to implement restructuring or repositioning strategies.
-
- Board alignment on value creation
- Transparent reporting and KPIs
- Strategic governance and exit planning
- Operational involvement with accountability
Diversity, Equity & Inclusion
We place a strong emphasis on women’s hormonal health, an area that remains chronically underserved even though women make up half the world’s population.
We favour companies that:
-
- Look to advance healthcare equity and long- term value for every patient group
- Encourage inclusive clinical and training environments
- Serve underserved demographics (e.g. women in menopause care)
Environmental Responsibility
We recognise the footprint of clinical operations and diagnostics. While not emissions-intensive, we are committed to tracking and improving environmental impact across our portfolio.
-
- Energy consumption and supplier-related emissions
- Waste management practices in clinical and lab settings
- Eco-conscious packaging and logistics for diagnostic products
